BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 24691704)

  • 1. Genotoxic and epigenetic mechanisms in arsenic carcinogenicity.
    Bustaffa E; Stoccoro A; Bianchi F; Migliore L
    Arch Toxicol; 2014 May; 88(5):1043-67. PubMed ID: 24691704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis.
    Ren X; McHale CM; Skibola CF; Smith AH; Smith MT; Zhang L
    Environ Health Perspect; 2011 Jan; 119(1):11-9. PubMed ID: 20682481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term arsenic exposure induces histone H3 Lys9 dimethylation without altering DNA methylation in the promoter region of p16(INK4a) and down-regulates its expression in the liver of mice.
    Suzuki T; Nohara K
    J Appl Toxicol; 2013 Sep; 33(9):951-8. PubMed ID: 22733434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of exposure to carcinogenic metals on histone tail modifications and gene expression in human subjects.
    Arita A; Shamy MY; Chervona Y; Clancy HA; Sun H; Hall MN; Qu Q; Gamble MV; Costa M
    J Trace Elem Med Biol; 2012 Jun; 26(2-3):174-8. PubMed ID: 22633395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of arsenic toxicity beyond epigenetic modifications.
    Bjørklund G; Aaseth J; Chirumbolo S; Urbina MA; Uddin R
    Environ Geochem Health; 2018 Jun; 40(3):955-965. PubMed ID: 28484874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic targets of arsenic: emphasis on epigenetic modifications during carcinogenesis.
    Roy RV; Son YO; Pratheeshkumar P; Wang L; Hitron JA; Divya SP; D R; Kim D; Yin Y; Zhang Z; Shi X
    J Environ Pathol Toxicol Oncol; 2015; 34(1):63-84. PubMed ID: 25746832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic effects of nano-sized materials.
    Stoccoro A; Karlsson HL; Coppedè F; Migliore L
    Toxicology; 2013 Nov; 313(1):3-14. PubMed ID: 23238276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of epigenetic events in genotoxic hepatocarcinogenesis induced by 2-acetylaminofluorene.
    Pogribny IP; Muskhelishvili L; Tryndyak VP; Beland FA
    Mutat Res; 2011 Jun; 722(2):106-13. PubMed ID: 20188851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review on arsenic carcinogenesis: Epidemiology, metabolism, genotoxicity and epigenetic changes.
    Zhou Q; Xi S
    Regul Toxicol Pharmacol; 2018 Nov; 99():78-88. PubMed ID: 30223072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms?
    Simeonova PP; Luster MI
    J Environ Pathol Toxicol Oncol; 2000; 19(3):281-6. PubMed ID: 10983894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinogen exposure and epigenetic silencing in bladder cancer.
    Marsit CJ; Karagas MR; Schned A; Kelsey KT
    Ann N Y Acad Sci; 2006 Sep; 1076():810-21. PubMed ID: 17119258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Exploration of Epigenetic Changes and DNA Methylation Markers Associated with Liver Tumors Induced by Inorganic Arsenite Exposure in Mice].
    Suzuki T; Nohara K
    Nihon Eiseigaku Zasshi; 2015; 70(3):181-5. PubMed ID: 26411935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic mechanisms underlying arsenic-associated lung carcinogenesis.
    van Breda SG; Claessen SM; Lo K; van Herwijnen M; Brauers KJ; Lisanti S; Theunissen DH; Jennen DG; Gaj S; de Kok TM; Kleinjans JC
    Arch Toxicol; 2015 Nov; 89(11):1959-69. PubMed ID: 25199682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer chemoprevention and nutriepigenetics: state of the art and future challenges.
    Gerhauser C
    Top Curr Chem; 2013; 329():73-132. PubMed ID: 22955508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications.
    Desaulniers D; Vasseur P; Jacobs A; Aguila MC; Ertych N; Jacobs MN
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selected mechanisms of genotoxic effects of inorganic arsenic compounds.
    Gradecka D; Palus J; Wasowicz W
    Int J Occup Med Environ Health; 2001; 14(4):317-28. PubMed ID: 11885915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epimutagenesis: A prospective mechanism to remediate arsenic-induced toxicity.
    Paul S; Giri AK
    Environ Int; 2015 Aug; 81():8-17. PubMed ID: 25898228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic modifications of DAPK and p16 genes contribute to arsenic-induced skin lesions and nondermatological health effects.
    Banerjee N; Paul S; Sau TJ; Das JK; Bandyopadhyay A; Banerjee S; Giri AK
    Toxicol Sci; 2013 Oct; 135(2):300-8. PubMed ID: 23872714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: A systematic literature review.
    Chappell G; Pogribny IP; Guyton KZ; Rusyn I
    Mutat Res Rev Mutat Res; 2016; 768():27-45. PubMed ID: 27234561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of miR-31 and SATB2 in arsenic-induced malignant BEAS-2B cell transformation.
    Chen QY; Li J; Sun H; Wu F; Zhu Y; Kluz T; Jordan A; DesMarais T; Zhang X; Murphy A; Costa M
    Mol Carcinog; 2018 Aug; 57(8):968-977. PubMed ID: 29603397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.